As of 2025-06-24, the Fair Value of AcelRx Pharmaceuticals Inc (ACRX) is -31.50 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.86 USD, the upside of AcelRx Pharmaceuticals Inc is -3,763.31%.
With the market price of 0.86 USD and our fair value calculation, AcelRx Pharmaceuticals Inc (ACRX) is not a good investment. Investing in ACRX stocks now will result in a potential loss of 3,763.31%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -47.15 | -53.24 | -40.38 | -35.10 | 47.76 | -25.62 |
| YoY growth | 8.46% | -12.92% | 24.15% | 13.08% | 236.07% | 53.77% |
| Market Cap (mil) | 14.58 |
| P/E | |
| Forward P/E | 1.17x |
| EPS | -1.26 |
| Avg earnings growth rate | 53.77% |
| TTM earnings | -21.36 |